MAZZOCCHETTI, PETRA
 Distribuzione geografica
Continente #
NA - Nord America 398
EU - Europa 237
AS - Asia 141
Totale 776
Nazione #
US - Stati Uniti d'America 398
IT - Italia 77
IE - Irlanda 66
SG - Singapore 42
HK - Hong Kong 34
CN - Cina 30
RO - Romania 29
VN - Vietnam 23
FR - Francia 19
DE - Germania 10
RU - Federazione Russa 9
KR - Corea 8
FI - Finlandia 6
SE - Svezia 6
CZ - Repubblica Ceca 5
GB - Regno Unito 4
CH - Svizzera 2
LB - Libano 2
AT - Austria 1
GR - Grecia 1
IN - India 1
RS - Serbia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 776
Città #
Chandler 111
Dublin 66
Perugia 40
Hong Kong 34
Singapore 32
Bucharest 27
Redmond 26
Altamura 23
Boardman 23
Dong Ket 23
San Mateo 20
Santa Clara 18
Des Moines 15
Lawrence 14
Medford 14
Princeton 14
Andover 11
Beijing 11
Wilmington 11
Seoul 8
Dallas 6
Los Angeles 6
Falls Church 5
Helsinki 4
Munich 4
Brno 3
Nagold 3
Prato 3
Rome 3
Saint Petersburg 3
Guangzhou 2
Hackney 2
Norwalk 2
Olomouc 2
San Paolo di Civitate 2
Shanghai 2
Timisoara 2
Ann Arbor 1
Ashburn 1
Cambridge 1
Chongqing 1
Fairfield 1
Frankfurt am Main 1
Fuzhou 1
Lappeenranta 1
Ludwigshafen am Rhein 1
Milan 1
Moscow 1
Xi'an 1
Totale 607
Nome #
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 110
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 81
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 71
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 63
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 56
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 51
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 50
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 50
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease 48
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 47
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 43
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 40
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 39
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 37
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 34
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits 15
Totale 835
Categoria #
all - tutte 3.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 3 4 6 3 12 1 3
2020/202178 0 0 2 0 22 6 2 13 4 3 0 26
2021/2022186 3 16 0 2 5 3 1 33 9 46 34 34
2022/2023294 15 61 4 33 22 39 0 18 91 1 7 3
2023/2024124 5 12 9 2 1 0 33 0 5 6 23 28
2024/202591 8 23 15 20 25 0 0 0 0 0 0 0
Totale 835